ClinicalTrials.gg
TerminatedNCT03357354Updated Jun 25, 2024

Program for Screening and Prevention of Eating Disorders in Obese Young People in Vulnerable Neighborhoods of Marseille: an Action Research

An interventional study of collective workshop in Obesity, sponsored by Assistance Publique Hopitaux De Marseille. Terminated at 1 site in France. Open to participants aged 11 Years to 17 Years. Per ClinicalTrials.gov, last updated 2024-06-25.

Sponsored by Assistance Publique Hopitaux De Marseille · Not applicable, Interventional, and Prevention

Why this study was terminated
difficulty of inclusion
Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Ages
11 Years to 17 Years
Sex
All
01

Study summary

Action research has been developed in this direction in order to use a tool to identify food disorder behavior among obese youths in their neighborhoods and social centers in vulnerable neighborhoods of Marseille, with the aim of a multi-professional therapeutic management (psychosocial support, theater) and a specialized orientation.

This program consists of the participation of each patient recruited in collective workshops. A total of 60 patients considered. Our hypothesis lies in the fact that for young people to participate in an adapted device, taking into account the global needs of young people and their entourage, would limit the deleterious effects of obesity and promote the young person's autonomy and allow him to be a actor in the request for care.

The project's objective is to provide support in the form of workshops with patients identified by the Marseille Hospitals Public Assistance Health Center as obese children and adolescents, in a precarious situation; to identify the presence of binge eating disorders and evaluate the impact of participation in these workshops on subsequent management by highly specialized professionals in food disorder behavior.

Read the detailed description

The mobile team (EM) of the Marseille Hospitals Public Assistance Health Center has the mission to inform, screen, support and guide the access to care of people in targeted neighborhoods, said to be vulnerable, by the city's policy of Marseille. The health space, a place of welcome and care, is located at a distance from any hospital structure within the most vulnerable neighborhoods of the city.

02

Conditions studied

  • Obesity

Browse trials for

03

In context

Obesity

6,578 studies on the registry are indexed under Obesity; 1,718 are open to participants now.

This study's enrollment of 15 is below the median of 77 across 5,084 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Assistance Publique Hopitaux De Marseille is the lead sponsor of 700 studies on the registry; 144 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Boys or girls aged 11 to 17
  • Reside in the territory of intervention of the mobile team, i.e the 3rd, 14th, 15th and 16th arrondissement of Marseille, districts said to be vulnerable by the city's policy.
  • Body mass index greater than or equal to IOTF-30 (HAS, 2011)
  • Social precariousness score EPICES greater than or equal to 30riteria:
  • Diagnosed Eating Disorder without medical and/or multi-professional care

Exclusion criteria

Exclusion Criteria:

  • Child with major difficulty of behavior
  • Patient with medical care
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (actual)

Study arms

  • Experimental
    Obese Children in precarious situations

    Behavioral: collective workshop

Interventions

  • Behavioralcollective workshop

    diet, sports games, food budget, feeling of satiety and hunger, self-image

06

What researchers measure

Primary outcomes

  1. Number of subjects included in the three months following the end of the workshops in a device specialized in the management of behavioral disorders.

    Tracking interview after the end of workshops

    Time frame: 6 MONTHS

Secondary outcomes

  1. Evaluation of with the ADO-BEDS

    children and teenagers will be asked to answer some items

    Time frame: 6 MONTHS

07

Study locations

1 site
  • Assistance Publique Hopitaux de Marseille
    Marseille, 13354, France
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Feb 2018 to primary completion in Mar 2020, 25 months.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 23, 2017
First posted
Nov 29, 2017
StartActual
Feb 1, 2018
Primary completionActual
Mar 4, 2020
CompletionActual
Mar 4, 2020
Last update
Jun 25, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 25, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03357354
Responsible party
Sponsor
First posted
Nov 29, 2017
Start date
Feb 1, 2018
Primary completion
Mar 4, 2020
Completion
Mar 4, 2020
Last update
Jun 25, 2024

Study contacts

Urielle DESALBRES
study director · Assistance Publique Hopitaux De Marseille

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion